Introduction

NIFEDULES LDC is a highly effective topical treatment containing a synergistic blend of Nifedipine and Lidocaine, specifically formulated to relieve pain and promote healing in anorectal disorders such as anal fissures and hemorrhoids. This advanced cream delivers dual-action benefits: vasodilation and local anesthesia — making it a top choice among healthcare professionals for non-surgical fissure management.

Composition

• Nifedipine – a calcium channel blocker that improves blood flow

• Lidocaine – a fast-acting local anesthetic that relieves pain

What is Nifedipine and Lidocaine Cream?

Nifedipine and Lidocaine cream is a topical pharmaceutical preparation used primarily in proctology. Nifedipine works by relaxing smooth muscle and dilating blood vessels, enhancing circulation in the anorectal area. Lidocaine provides immediate relief by numbing the area and reducing nerve signal transmission.This powerful combination reduces pain, swelling, and muscle spasm — all of which contribute to the persistence of chronic anal fissures. The cream not only eases symptoms but also accelerates healing, potentially preventing the need for surgery.

Nifedipine and Lidocaine Cream Uses

NIFEDULES LDC is used for the treatment of:

• Acute and chronic anal fissures

• Post-surgical anal pain

• Internal and external hemorrhoids

• Painful bowel movements

• Anal itching and burning sensation

This cream is ideal for patients who cannot tolerate oral medications or surgery and is a preferred first-line topical treatment.

How It Works

• Nifedipine: A vasodilator that reduces anal sphincter pressure, increases blood flow, and promotes tissue repair.

• Lidocaine: A local anesthetic that blocks sodium channels, preventing pain signal transmission to the brain.

This dual mechanism offers both symptomatic relief and healing, making it more effective than single-agent therapies.

Benefits of NIFEDULES LDC

• Fast pain relief and muscle relaxation

• Promotes fissure healing without surgery

• Reduces anal pressure and vascular spasm

• Non-invasive and well-tolerated topical treatment

• Improves quality of life in anorectal conditions

• Minimizes risk of recurrence when used as directed

How to Use NIFEDULES LDC

1. Clean the affected area with warm water and pat dry gently.

2. Apply a small amount of the cream using a gloved finger or applicator.

3. Use 2 to 3 times daily, preferably after bowel movements.

4. Wash hands thoroughly after application.

5. Avoid using on open wounds or infected areas unless prescribed.

Duration: Treatment is usually recommended for 2–6 weeks, depending on the severity and response.

Precautions & Warnings

• For external use only

• Avoid contact with eyes and mucous membranes

• Not recommended for use in pregnancy or lactation unless directed by a physician

• Do not use for prolonged periods without medical advice

• Discontinue use in case of allergy, irritation, or no improvement

Possible Side Effects

Though generally well-tolerated, some users may experience:

• Mild burning or itching

• Localized redness

• Temporary numbness

• Rare allergic reactions

If symptoms persist or worsen, seek medical advice.

Frequently Asked Questions (FAQs)

Q1. What is Nifedipine and Lidocaine cream used for?
It is used to treat anal fissures, hemorrhoids, and anal pain, providing relief and promoting healing.

Q2. How does Nifedipine Lidocaine cream work?
Nifedipine relaxes muscles and improves blood flow, while Lidocaine numbs the area to reduce pain.

Q3. Is Nifedipine cream safe?
Yes, when used as prescribed, it is safe and effective. Always follow your doctor’s instructions.

Q4. Can it be used for hemorrhoids?
Yes, it helps reduce swelling, discomfort, and pain caused by internal or external hemorrhoids.

Q5. How long should I use this cream?
Use for 2 to 6 weeks, or as advised by your healthcare provider.

Q6. Can I use Nifedipine and Lidocaine cream during pregnancy?
Consult your doctor before use during pregnancy or breastfeeding.

Conclusion

NIFEDULES LDC is an advanced, non-invasive, and highly effective treatment for anal fissures and hemorrhoids, combining the best of vasodilation and local anesthesia in one product. With strong clinical support and patient satisfaction, it's a trusted solution for rapid relief and recovery in anorectal disorders.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW

News Referrences:

• Mumbai Based Steris Healthcare Announces Expansion Plan IPO Launch: msn.com
• Steris Healthcare Unveils Rs 50 Crore Expansion Plan, Eyes IPO In FY 2026-27: bwhealthcareworld.com
• Mumbai-based Steris Healthcare Pvt Ltd plans to launch IPO in FY 2026-27: indianstartupnews.com
• Steris Healthcare Announces Rs 50 Crore Expansion, IPO Planned For FY 2026-27: News18.com
• Steris Healthcare Pvt Ltd announces 50 crore expansion and IPO plans for FY 2026-- 27: expresspharma.com
• Steris Healtcare: Our Brand Is List On Trusted News Plateform.

Steris Healthcare, a pharmaceutical company headquartered in Mumbai, has announced a strategic expansion plan worth 50 crore. The initiative includes setting up a new manufacturing facility in South India, doubling its current production capacity, and preparing for an Initial Public Offering (IPO) scheduled for the financial year 2026-- 27.

Having surpassed 100 crore in annual sales, Steris Healthcare aims to strengthen its nationwide footprint by expanding into key southern markets such as Kerala, Tamil Nadu, Telangana, and Karnataka. The upcoming manufacturing unit is expected to play a crucial role in enhancing the company's production capabilities and meeting the rising demand from both domestic and international markets.